Insider Trading Alert - TUP, FITB And MJN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 4, 2015, 82 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1.50 to $744,000,000,054.72.

Highlighted Stocks Traded by Insiders:

Tupperware Brands (TUP) - FREE Research Report

Timmerman Jose R, who is EVP, Supply Chain, Worldwide at Tupperware Brands, sold 10,572 shares at $67.10 on May 4, 2015. Following this transaction, the EVP, Supply Chain, Worldwide owned 27,489 shares meaning that the stake was reduced by 27.78% with the 10,572-share transaction.

Poteshman Michael S, who is Executive Vice President & CFO at Tupperware Brands, sold 4,000 shares at $66.86 on May 4, 2015. Following this transaction, the Executive Vice President & CFO owned 9,218 shares meaning that the stake was reduced by 30.26% with the 4,000-share transaction.

The shares most recently traded at $65.84, down $1.02, or 1.55% since the insider transaction. Historical insider transactions for Tupperware Brands go as follows:

  • 4-Week # shares sold: 23,247
  • 12-Week # shares sold: 34,333
  • 24-Week # shares sold: 46,333

The average volume for Tupperware Brands has been 587,500 shares per day over the past 30 days. Tupperware Brands has a market cap of $3.3 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 6.08% year-to-date as of the close of trading on Monday.

Tupperware Brands Corporation operates as a direct-to-consumer marketer of various products across a range of brands and categories worldwide. The stock currently has a dividend yield of 4.07%. The company has a P/E ratio of 17.7. Currently, there are 2 analysts who rate Tupperware Brands a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TUP - FREE

TheStreet Quant Ratings rates Tupperware Brands as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Tupperware Brands Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Fifth Third Bancorp (FITB) - FREE Research Report

Brumback Emerson L, who is Director at Fifth Third Bancorp, sold 1,750 shares at $20.18 on May 4, 2015. Following this transaction, the Director owned 42,134 shares meaning that the stake was reduced by 3.99% with the 1,750-share transaction.

The shares most recently traded at $20.48, up $0.30, or 1.44% since the insider transaction. Historical insider transactions for Fifth Third Bancorp go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 35,000
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 49,835
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 49,835

The average volume for Fifth Third Bancorp has been 8.1 million shares per day over the past 30 days. Fifth Third Bancorp has a market cap of $16.5 billion and is part of the financial sector and banking industry. Shares are down 0.66% year-to-date as of the close of trading on Monday.

Fifth Third Bancorp operates as a diversified financial services company in the United States. It operates through four segments: Commercial Banking, Branch Banking, Consumer Lending, and Investment Advisors. The stock currently has a dividend yield of 2.57%. The company has a P/E ratio of 11.6. Currently, there are 7 analysts who rate Fifth Third Bancorp a buy, no analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FITB - FREE

TheStreet Quant Ratings rates Fifth Third Bancorp as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Fifth Third Bancorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Mead Johnson Nutrition (MJN) - FREE Research Report

Urbain Charles M, who is SVP,Stakeholder Relations/CDO at Mead Johnson Nutrition, sold 5,000 shares at $95.89 on May 4, 2015. Following this transaction, the SVP,Stakeholder Relations/CDO owned 45,623 shares meaning that the stake was reduced by 9.88% with the 5,000-share transaction.

The shares most recently traded at $96.88, up $0.99, or 1.02% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 15,000
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 38,874

The average volume for Mead Johnson Nutrition has been 1.1 million shares per day over the past 30 days. Mead Johnson Nutrition has a market cap of $19.5 billion and is part of the consumer goods sector and food & beverage industry. Shares are down 4.27% year-to-date as of the close of trading on Monday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The stock currently has a dividend yield of 1.71%. The company has a P/E ratio of 27.0. Currently, there are 4 analysts who rate Mead Johnson Nutrition a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings rates Mead Johnson Nutrition as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, expanding profit margins, growth in earnings per share, increase in stock price during the past year and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Mead Johnson Nutrition Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists